Back to 
Natixis
Natixis
QNCX
Showing 0 of 6 quarters
Position history for Natixis's holdings in QUINCE THERAPEUTICS INC
No. Natixis exited its QNCX (Quince Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 6,114 shares worth $306,000. Natixis first reported QNCX in Q3 2019 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.